Stardust Power 3Q 2026: Revenue $0, EPS ($0.15) — 10-Q Summary

Stardust Power reported no revenue in 3Q 2026, with a net loss of $2.77M, narrower than the prior year. Expenses fell due to stock-based compensation reversals, but interest expense and derivative losses partially offset gains. The company secured a key permit and a lithium supply agreement, but Nasdaq trading suspension hindered funding.

Original reporting
Published Nov 13, 2026, 10:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 10:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stardust Power 3Q 2026: Revenue $0, EPS ($0.15) — 10-Q Summary — source image
Decision brief

The 30-second read

$SDSTBearishLow
01

Why it matters

The earnings release confirms continued operating losses but shows cost discipline and progress on permitting, which may affect future financing and valuation.

02

Market read

Primary earnings disclosure for a listed micro‑cap; new numbers may move the stock modestly.

03

What to watch

Nasdaq trading suspension limits liquidity; the permitting milestone may unlock financing later.

Relevance 6/10Novelty 7/10Timing: after‑hours release

Background

Stardust Power Inc. filed its Q3 2026 Form 10‑Q, highlighting zero revenue, a narrowed loss, a new Oklahoma air‑quality permit, and a 12‑year lithium‑chloride feedstock agreement.

Company-level read

Ticker impact

$SDSTBearishMedium confidence
Context

Q3 2026 10‑Q shows zero revenue and a narrowed net loss of $2.77M, EPS -$0.15 versus a $4.46M loss a year ago.

Expected impact

modest downside as investors weigh continued loss despite expense cuts

Evidence & confidence

The company still reports a loss and negative EPS; the improvement is modest and unlikely to spark a rally.

Market effects

Limited impact on the broader lithium‑chemical sector; the permit and feedstock agreement may be noted by peers.

Primarily relevant to U.S. over‑the‑counter investors in micro‑caps.

Minimal; no macro‑economic or geopolitical link.

Counterpoint

The expense reductions and new feedstock contract could lay groundwork for future upside if the plant reaches capacity.

Key entities

  • Stardust Power Inc.

    Micro‑cap energy company reporting Q3 2026 results.

Related articles

$SDSTMed

Stardust Power signs lithium supply deal with Charge CCCV

Stardust Power (NASDAQ: SDST) said it signed a non-binding Letter of Intent with battery technology firm Charge CCCV LLC (C4V) to supply battery-grade lithium carbonate from its Muskogee, Oklahoma refinery. C4V’s preliminary demand forecast calls for 3,000 MT in 2028, 10,000 MT in 2029, and 20,000 MT by 2030. Stardust noted the deal could cover much of planned output and generate billions if prices stay near current levels.

$BTOMedAI 8/10

B2Gold Earnings Call Signals Lower Costs and Growth

B2Gold Corp. reported Q3 earnings with strong production, lower cost guidance, and positive free cash flow. The company produced 193,000 ounces of gold, reduced all-in sustaining cost guidance by over $100 per ounce, and generated $48 million in free cash flow. Revenue reached $836 million, supported by higher gold prices. The company also highlighted growth projects and shareholder returns.

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.